Hallmarks of aging

Aging is not a single process. It is at least 12 converging ones, each measurable, each mechanistically linked to the others, and each, in principle, targetable. The hallmarks of aging framework, first published by López-Otín and colleagues in 2013 with nine hallmarks and expanded to twelve in 2023, is the closest thing biology has to a unified theory of why bodies break down [1] [2].

What earns something the label "hallmark"

The criteria are deliberately strict. A process qualifies only if it (1) appears during normal aging, (2) causes faster aging when experimentally worsened, and (3) slows aging when experimentally corrected, genetically or pharmacologically [1]. That three-part test keeps the framework from becoming a list of aging's symptoms. Each hallmark is, at least in animal models, a lever.

The twelve hallmarks, organized by role

The 2023 taxonomy groups the twelve into three tiers [2].

Primary hallmarks are upstream causes that accumulate steadily with age. Genomic instability covers the slow buildup of DNA damage, double-strand breaks, oxidative lesions, replication errors, alongside declining repair capacity. Telomere attrition describes the progressive shortening that eventually triggers cells to stop dividing. Epigenetic alterations capture the drift in DNA methylation patterns and histone modifications that researchers now quantify with aging clocks. Loss of proteostasis reflects the gradual failure of the machinery that folds, clears, and recycles proteins, allowing aggregates like amyloid-beta and tau to accumulate. Disabled macroautophagy, added in 2023, is closely related: lysosomal clearance of damaged organelles falters, and mitophagy, the targeted removal of dysfunctional mitochondria, declines [2].

Antagonistic hallmarks are responses that start protective but turn damaging when they persist. Deregulated nutrient-sensing includes chronic overactivation of mTORC1 and declining AMPK and sirtuin activity, a state that mimics being perpetually overfed. Mitochondrial dysfunction involves inefficient electron transport, excess reactive oxygen species, and impaired energy output. Cellular senescence describes growth-arrested cells that refuse to die and instead secrete a pro-inflammatory cocktail, IL-6, IL-8, matrix metalloproteinases, and others, collectively called the SASP. Chronic inflammation, also added in 2023, is the systemic result: a low-grade, sterile, persistent inflammatory state driven by SASP, gut changes, and innate immune dysregulation [2].

Integrative hallmarks are the downstream consequences visible at the tissue and organ level. Stem cell exhaustion describes the depletion of tissue-resident stem cell pools, blood, muscle, neural, that leaves organs unable to repair themselves. Altered intercellular communication reflects how circulating signals, exosomes, and microRNAs shift with age, disrupting coordination between tissues. Dysbiosis, the third 2023 addition, covers the age-associated microbiome shift toward fewer butyrate-producing bacteria, more Proteobacteria, and greater intestinal permeability [2].

How interventions map onto the hallmarks

The framework gives researchers and clinicians a way to categorize what a given intervention is doing [2]. Caloric restriction and fasting engage disabled macroautophagy, mitochondrial dysfunction, and nutrient-sensing simultaneously. NAD+ precursors like NR and NMN address genomic instability (through PARP1 and sirtuin-mediated DNA repair) and nutrient-sensing. Senolytics target cellular senescence directly. Epigenetic reprogramming strategies, still in preclinical stages, aim at hallmark three. Exercise touches mitochondrial dysfunction, nutrient-sensing, senescence, and inflammation, and carries observational evidence linking cardiorespiratory fitness to all-cause mortality outcomes, though no randomized trial has tested it against an all-cause mortality primary endpoint.

The framework's real limits

The hallmarks are a taxonomy, not a proof of causation in humans. Satisfying all three hallmark criteria in mice or worms does not confirm that correcting the same process extends healthy human lifespan. That gap is wide and largely unfilled. Rapamycin robustly engages autophagy and nutrient-sensing hallmarks in mice, but human longevity evidence remains thin [2]. NMN and NR improve NAD+ levels in humans but have not shown meaningful functional benefits in healthy adults in completed trials.

The hallmarks also interact in ways that complicate attribution. Senescent cells drive inflammaging; gut dysbiosis worsens senescence; epigenetic drift correlates with genomic instability. An intervention hitting one hallmark almost certainly moves others, which makes it hard to know what is doing the work.

Where the evidence is contested

The framework itself carries broad consensus among aging biologists, but its clinical translation is disputed. One position, associated with researchers like López-Otín, David Sinclair, and Peter Attia, holds that the hallmarks provide an actionable map for targeting aging now, even before definitive human outcome trials exist [2]. The opposing view holds that without randomized controlled trial evidence linking hallmark correction to human healthspan or lifespan outcomes, the framework is scientifically valuable but premature as a guide to intervention. NMN/NR illustrates the tension: NAD+ restoration is mechanistically well-grounded in hallmark biology, yet functional outcomes in healthy humans are null in completed trials. Neither side disputes the biology; the disagreement is about how far ahead of the evidence it is reasonable to act.

References

1. López-Otín C et al. 2013 (Cell) — "The Hallmarks of Aging"; 9 hallmarks taxonomy; ~14,000 citations; the foundational framework · PubMed 23746838
2. López-Otín C et al. 2023 (Cell) — "Hallmarks of aging: An expanding universe"; adds disabled macroautophagy, inflammaging, dysbiosis; 9→12 hallmarks · PubMed 36599349